Does Rallies show 13F holders for AHCO?

Yes. Rallies tracks hedge fund and 13F ownership data for AHCO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AHCO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AHCO. It does not provide personalized investment advice.

AHCO (AdaptHealth Corp. Common Stock) Stock Analysis - Hedge Fund Holdings

AdaptHealth Corp. Common Stock (AHCO) is a publicly traded Healthcare sector company. As of May 21, 2026, AHCO trades at $10.47 with a market cap of $1.46B and a P/E ratio of -17.84. AHCO moved +1.35% today. Year to date, AHCO is +7.16%; over the trailing twelve months it is +13.30%. Its 52-week range spans $7.11 to $13.43. Analyst consensus is buy with an average price target of $13.93. Rallies surfaces AHCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AHCO stock?

Hedge funds tracked by Rallies that own AHCO include Maverick Capital, Mangrove Partners, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AdaptHealth Corp. Common Stock.

AHCO Key Metrics

Key financial metrics for AHCO
Metric	Value
Price	$10.47
Market Cap	$1.46B
P/E Ratio	-17.84
EPS	$-0.59
Dividend Yield	0.00%
52-Week High	$13.43
52-Week Low	$7.11
Volume	3
Avg Volume	0
Revenue (TTM)	$3.29B
Net Income	$-74.83M
Gross Margin	18.26%

Top Hedge Funds Holding AHCO

Maverick Capital holds 1.18M shares of AHCO, changed -10.86% as of Jun 30, 2024.
Mangrove Partners holds 164.96K shares of AHCO, changed +0.00% as of Mar 31, 2026.
Bridgewater Associates holds 11.68K shares of AHCO, changed -71.34% as of Dec 31, 2024.

Latest AHCO News

AdaptHealth Raises Outlook on West Coast Capitated Contract and 80% CPAP Adherence — Mar 4, 2026
AdaptHealth stock plunges 16.4% after Q4 revenue beat but posts $0.76/share GAAP loss — Feb 24, 2026
AdaptHealth Reports Q4 EPS $0.27, Misses Estimates and Issues 2026 Guidance — Feb 24, 2026
AdaptHealth Posts $820.3M Q3 Revenue (+1.8% YoY) as Q4 Earnings Loom — Feb 23, 2026

Recent AHCO Insider Trades

OEP VII GP, L.L.C. bought 447.10K (~$4.43M) on Mar 20, 2026.
CASHIN RICHARD M JR bought 447.10K (~$4.43M) on Mar 20, 2026.
OEP VII GP, L.L.C. bought 727 (~$7.23K) on Mar 19, 2026.

AHCO Analyst Consensus

7 analysts cover AHCO: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.93.

Common questions about AHCO

Who owns AHCO stock?: Hedge funds tracked by Rallies that own AHCO include Maverick Capital, Mangrove Partners, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AdaptHealth Corp. Common Stock.
Does Rallies show 13F holders for AHCO?: Yes. Rallies tracks hedge fund and 13F ownership data for AHCO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AHCO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AHCO. It does not provide personalized investment advice.